Operating Lease, Right-of-Use Asset of ImmunityBio, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ImmunityBio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • ImmunityBio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $33,195,000, a 5% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ImmunityBio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $33,195,000 -$1,751,000 -5% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $34,723,000 +$906,000 +2.7% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $31,780,000 -$3,417,000 -9.7% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $33,363,000 -$3,180,000 -8.7% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $34,946,000 -$864,000 -2.4% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $33,817,000 -$8,738,000 -21% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $35,197,000 -$8,994,000 -20% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $36,543,000 -$9,245,000 -20% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $35,810,000 -$10,619,000 -23% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $42,555,000 -$5,548,000 -12% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $44,191,000 +$8,294,000 +23% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $45,788,000 +$9,484,000 +26% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 $46,429,000 +$12,330,000 +36% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $48,103,000 +$19,873,000 +70% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $35,897,000 +$17,450,000 +95% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $36,304,000 +$18,166,000 +100% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $34,099,000 +$19,497,000 +134% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $28,230,000 +$17,823,000 +171% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $18,447,000 +$7,392,000 +67% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $18,138,000 -$1,993,000 -9.9% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $14,602,000 +$2,195,000 +18% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $10,407,000 -$2,106,000 -17% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $11,055,000 -$2,100,000 -16% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $20,131,000 +$20,131,000 31 Dec 2019 8-K/A 22 Apr 2021
Q3 2019 $12,407,000 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $12,513,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $13,155,000 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 25 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.